Crop Life ScienceNSE:CLSL -0.64%64 Return-on-Tangible-Equity is 8.95% as of Mar. 2026, which is 17% below its 10-year median of 10.74. GuruFocus rates NSE:CLSL with a GF Score™ of 64/100 and a GF Value™ of ₹55.10 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 248 Agriculture companies, Crop Life Science ranks better than 51.61% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Crop Life Science's annualized net income for the quarter that ended in Mar. 2026 was ₹72 Mil. Crop Life Science's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹799 Mil. Therefore, Crop Life Science's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 8.95%.
The historical rank and industry rank for Crop Life Science's Return-on-Tangible-Equity or its related term are showing as below:
NSE:CLSL'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 8.19 Med: 10.74 Max: 11.98
Current: 8.48
During the past 7 years, Crop Life Science's highest Return-on-Tangible-Equity was 11.98%. The lowest was 8.19%. And the median was 10.74%.
NSE:CLSL's Return-on-Tangible-Equity is ranked better than 51.61% of 248
companies
in the Agriculture industry
Industry Median: 7.89
vs NSE:CLSL: 8.48
Crop Life Science (NSE:CLSL) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Crop Life Science Return-on-Tangible-Equity Related Terms
Crop Life Science Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Crop Life Science's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CLSL vs CTVA, CF, MOS: Return-on-Tangible-Equity Comparison
For the Agricultural Inputs subindustry, Crop Life Science's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Crop Life Science Return-on-Tangible-Equity vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Crop Life Science's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Crop Life Science's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 8.95% mean?
Crop Life Science (NSE:CLSL) has a Return-on-Tangible-Equity of 8.95% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Crop Life Science and its competitors. This is 17% below median its historical median of 10.74. Over the past decade, Crop Life Science's Return-on-Tangible-Equity has ranged from 8.19 to 11.98. According to the industry distribution chart, Crop Life Science ranks #120 out of 248 companies in the Agriculture industry, placing it in the top 48.4%.
Is Crop Life Science's Return-on-Tangible-Equity too high?
Crop Life Science's current Return-on-Tangible-Equity of 8.95% is 17% below median its 10-year median of 10.74. Over the past 10 years, this metric has ranged from a low of 8.19 to a high of 11.98. The Agriculture industry median Return-on-Tangible-Equity is 7.89. Crop Life Science's value of 8.95% is 13.4% above this industry median. Based on the distribution chart, Crop Life Science ranks #120 out of 248 companies in the Agriculture industry, which is above the industry midpoint. Overall, Crop Life Science has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's Return-on-Tangible-Equity compare to CTVA and CF?
According to the Agriculture industry distribution chart, Crop Life Science ranks #120 out of 248 companies for Return-on-Tangible-Equity. This puts Crop Life Science in the upper half of its industry. The industry median Return-on-Tangible-Equity is 7.89. Crop Life Science's value of 8.95% is 13.4% above this benchmark. Historically, Crop Life Science's own Return-on-Tangible-Equity has ranged from 8.19 to 11.98 over the past decade. While the company's 10-year median is 10.74 vs. the industry median of 7.89, Crop Life Science has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for an Agriculture company?
The median Return-on-Tangible-Equity among Agriculture companies is 7.89, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Crop Life Science's current Return-on-Tangible-Equity of 8.95% is 13.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Crop Life Science and its competitors. For the Agriculture industry, the median Return-on-Tangible-Equity is 7.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Crop Life Science's current Return-on-Tangible-Equity is 8.95%, which is 17% below median its own 10-year median of 10.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹55.10, compared to a current price of ₹46.25 — trading 16.1% below its estimated fair value. The current Return-on-Tangible-Equity is 8.95%, which is 17% below median its 10-year median of 10.74 and 13.4% above the Agriculture industry median of 7.89. Crop Life Science's overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current Return-on-Tangible-Equity is 8.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Crop Life Science (NSE:CLSL) Overvalued in 2026?
Based on GuruFocus' analysis, Crop Life Science stock appears to be undervalued.
The current stock price of ₹46.25 is trading 16.1% below its estimated GF Value™ of ₹55.10.
GuruFocus considers Crop Life Science to be Modestly Undervalued.
Key valuation signals for NSE:CLSL:
Return-on-Tangible-Equity: 8.95% (17% below median its 10-year median of 10.74)
GF Value™: ₹55.10 vs. price of ₹46.25 (16.1% below fair value)
Industry Position: 13.4% above the Agriculture median (#120 of 248)
No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
64GF Score
Get the complete analysis for NSE:CLSL
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CLSL has been successfully added to your 
